Evidence map›Paper›PMID 34965978›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2022

Cross Talk between α7 and α3β4 Nicotinic Receptors Prevents Their Desensitization in Human Chromaffin Cells.

Amanda Jiménez-Pompa, Sara Sanz-Lázaro, Romidan Ewere Omodolor, José Medina-Polo, Carmen González-Enguita, Jesús Blázquez, J Michael McIntosh, Almudena Albillos

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. The Role of Nicotinic Receptors on CaCurrent issues in molecular biology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Amanda Jiménez-PompaDepartamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid 28029, Spain.ORCID 0000-0001-7625-2616
Sara Sanz-LázaroDepartamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid 28029, Spain.
Romidan Ewere OmodolorDepartamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid 28029, Spain.
José Medina-PoloServicio de Urología, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid 28041, Spain.
Carmen González-EnguitaServicio de Urología y Unidad de Trasplante Renal, Fundación Jiménez Díaz, Madrid 28040, Spain.
Jesús BlázquezServicio de Urología, Hospital Clínico San Carlos, Madrid 28040, Spain.
J Michael McIntoshDepartments of Biology and Psychiatry, University of Utah, Salt Lake City, UT 84108.
Almudena AlbillosDepartamento de Farmacología y Terapéutica, Universidad Autónoma de Madrid, Madrid 28029, Spain almudena.albillos@uam.es.
Universidad Autónoma de Madrid · ESFundación Instituto para la Mejora de la Asistencia Sanitaria · ESHospital Clínico San Carlos · ESHospital Universitario Fundación Jiménez Díaz · ESInstituto Cajal · ESResearch Institute Hospital 12 de Octubre · ESUniversity of Utah · US

Funding

Novel nAChR-Targeted PeptidesR01GM103801 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2012 to 2019
$2.4M
Development and Application of Nicotinic Acetylcholine Receptor Targeted Peptides for Biomedical ResearchR35GM136430 · NIGMS · UNIVERSITY OF UTAH · PI MCINTOSH, J MICHAEL · 2020 to 2024
$2.3M
NIGMS NIH HHS R01 GM103801NIGMS NIH HHS R35 GM136430
6 · The paper itself

Abstract

The physical interaction and functional cross talk among the different subtypes of neuronal nicotinic acetylcholine receptors (nAChRs) expressed in the various tissues is unknown. Here, we have investigated this issue between the only two nAChRs subtypes expressed, the α7 and α3β4 subtypes, in a human native neuroendocrine cell (the chromaffin cell) using electrophysiological patch-clamp, fluorescence, and Förster resonance energy transfer (FRET) techniques. Our data show that α7 and α3β4 receptor subtypes require their mutual and maximal efficacy of activation to increase their expression, to avoid their desensitization, and therefore, to increase their activity. In this way, after repetitive stimulation with acetylcholine (ACh), α7 and α3β4 receptor subtypes do not desensitize, but they do with choline. The nicotinic current increase associated with the α3β4 subtype is dependent on Ca

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsChromaffin CellsHumansMiceMice, Inbred C57BLReceptor Cross-TalkReceptors, Nicotinicalpha7 Nicotinic Acetylcholine Receptornicotinic receptor alpha3beta4Receptors, Nicotinicchromaffin cellhumannicotinic receptorpatch-clampα3β4α7

Identifiers

PMID34965978
PMCPMC8883849
OpenAlexW4200122262

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.